| Literature DB >> 33376770 |
José Augusto Rodrigues Santos1, Ricardo J Fernandes1,2, Rodrigo Zacca1,2,3.
Abstract
Intensive physical training programs can affect the immune system. This study aims to verify the multi-micronutrient supplementation effects on serum immunoglobulins levels prior to and after a five-week physical training program. Twenty-four male recruit firefighters were randomly allocated into supplemented (with Prisfar Ever-Fit Plus over 35 consecutive days) and placebo groups (n=12 each). Serum immunoglobulins G, A, and M were assessed. Supplementation effect was detected for immunoglobulin G (eta-squared, η 2 : 0.09; p =0.035; power: 0.56), A (η 2 : 0.24; p =0.001; power: 0.95), and M (η 2 : 0.09; p =0.036; power: 0.56). Although immunoglobulin A was different between groups at baseline (mean difference: 42.58; 95%CI: 7.00 to 78.16 mg/dL; p =0.021; d =2.48), within-group (before vs . after five weeks) showed no differences for both supplemented and control groups. In addition, even if immunoglobulin G and M were similar at baseline, immunoglobulin G decreased (mean diff.: 46.4; 95%CI: 6.7 to 86.1 mg/dL; p =0.03; d =0.74) and immunoglobulin M increased (mean diff.: -10.7; 95%CI: -15.8 to -5.5 mg/dL; p =0.001; d =-1.33) in the control group. Although mean values remained within the reference values, changes observed for immunoglobulin G and M may reflect some immune protection for firefighters engaged in recruit training. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Keywords: exercise; firefighters; immunoglobulin; nutrition; training
Year: 2020 PMID: 33376770 PMCID: PMC7758155 DOI: 10.1055/a-1296-1486
Source DB: PubMed Journal: Sports Med Int Open ISSN: 2367-1890
Table 1 Means and standard deviation (±SD) values of age, anthropometrics, and physical conditioning characteristics of supplemented and placebo group.
| Variables | Supplemented (n=12) | Placebo (n=12) | Paired t-test |
|---|---|---|---|
|
| 22.1±1.9 | 23.9±0.3 | ns |
|
| 174.5±3.8 | 174.3±3.5 | ns |
|
| 68.9±7.4 | 69.3±12.3 | ns |
|
| 9.6±2.0 | 10.2±2.0 | ns |
|
| 12.0±7.1 | 13.7±5.7 | ns |
|
| 15.8±0.7 | 15.7±2.1 | ns |
|
| 7.00±0.0 | 6.97±0.05 | ns |
|
| 3007±127 | 3120±106 | ns |
|
| 10.5±0.5 | 10.8±0.1 | ns |
|
| 7.8±0.5 | 8.1±0.3 | ns |
|
| 5.7±0.8 | 5.8±0.6 | ns |
|
| 45.9±6.4 | 45.2±6.8 | ns |
|
| 37.3±5.7 | 37.8±3.5 | ns |
|
| 38.3±6.2 | 39.4±5.8 | ns |
ns: t-test non-significant (p>0.05); *Wingate test.
Fig. 1The physical training program.
Table 2 Means and standard deviation (±SD) values regarding nutritional intake before supplementation for both groups.
| Supplemented (n=12) | Placebo (n=12) | Paired t-test | |
|---|---|---|---|
|
| 3050±600 | 2985±580 | ns |
|
| 51.2±5.8 | 50.8±3.1 | ns |
|
| 18.4±2.5 | 19.2±2.1 | ns |
|
| 30.2±3.3 | 30.8±2.8 | ns |
|
| 147.2±58.2 | 152.8±47.3 | ns |
|
| 7.9±2.3 | 8.3±2.8 | ns |
|
| 165.1±4.3 | 158.3±7.2 | ns |
|
| 431.4±76.8 | 411.9±82.5 | ns |
|
| 163.3±22.7 | 161.9±54.2 | ns |
|
| 16.9±5.7 | 17.1±4.2 | ns |
ns: t-test non-significant (p>0.05);
Table 3 IgG, IgA, and IgM for the supplemented (SUP) and placebo (PLA) groups before and after the training period.
| Variables | Group | Before |
Mean diff (95%CI); Sig.; Cohen’s
| After |
Mean diff (95%CI); Sig.; Cohen’s
| |
|---|---|---|---|---|---|---|
| Between-Group (Before) |
Within-Group (Before
| |||||
| IgG (mg/dL) | SUP | 909.0±120.7 | 90.50 (−63.9 to 244.9); 0.237; 1.21 | 918.9±171.2 | −9.9 (−61.8 to 42.0); 0.68; −0.12 |
|
| PLA | 818.5±228.0 | 772.1±216.1 | 46.4 (6.7 to 86.1); 0.03*; 0.74* |
| ||
| IgA (mg/dL) | SUP | 176.5±42.2 | 42.58 (7.00 to 78.16); 0.021*; 2.48* | 186.1±48.5 | −9.6 (−24.5 to 5.4); 0.19; −0.40 |
|
| PLA | 133.9±41.8 | 133.7±43.3 | 0.2 (−8.8 to 9.3); 0.95; 0.01 |
| ||
| IgM (mg/dL) | SUP | 65.9±20.2 | −16.00 (−41.2 to 9.25); 0.202; 0.01 | 69.7±20.8 | −3.8 (−7.8 to 0.1); 0.06; −0.61 |
|
| PLA | 81.9±37.0 | 92.6±40.5 | −10.7 (−15.8 to −5.5); 0.001*; −1.33* |
| ||
*P<0.05, ≈ similar, ↓decreased and ↑increased.